Hearing loss (HL) is associated with increased neuroinflammation (Shen et al. 2021) and amyloid deposition (Zheng et al. 2022), which may further worsen cognitive decline, linking APP, PSEN, and ApoE to familial and sporadic AD progression, particularly in the presence of HL. Here, APP is linked to Hodgkins lymphoma.